Sign Up Today and Learn More About Click Therapeutics Stock
Invest in or calculate the value of your shares in Click Therapeutics or other pre-IPO companies through EquityZen's platform.
Click Therapeutics Stock (CLTH)
Digital Therapeutics Applications
About Click Therapeutics Stock
Founded
2012
Headquarters
New York, NY, US
Total Funding
37.1M
Industries
Science and Engineering, Health Care, Biotechnology
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Click Therapeutics Press Mentions
Stay in the know about the latest news on Click Therapeutics
Click Therapeutics Launches Software-Enhanced Drug™ Therapies as Part of New Click SE™ Offering
businesswire • Oct 30, 2024
Click Therapeutics buys shuttered Better Therapeutics’ assets
massdevice • Aug 04, 2024
Click Therapeutics picks up Better's app assets in diabetes, obesity
fiercebiotech • Jul 24, 2024
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
businesswire • Jul 24, 2024
Click Therapeutics acquires Better Therapeutics assets
axios • Jun 26, 2024
Investors in Click Therapeutics
Discover investors in Click Therapeutics stock and explore their portfolio companies
Click Therapeutics Management
Leadership team at Click Therapeutics
Chief Executive Officer
David Benshoof Klein
Chief Technology Officer
Christopher Jordan
Join now and verify your accreditation status to gain access to:
- Click Therapeutics current valuation
- Click Therapeutics stock price
- Available deals in Click Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Click Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Click Therapeutics through EquityZen funds. These investments are made available by existing Click Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Click Therapeutics stock?
Shareholders can sell their Click Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
